-+ 0.00%
-+ 0.00%
-+ 0.00%

Unicycive Therapeutics Q3 EPS $(0.25) Beats $(0.31) Estimate

Benzinga·11/16/2026 12:18:25
Listen to the news
Unicycive Therapeutics (NASDAQ:UNCY) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.31) by 19.35 percent. This is a 24.24 percent increase over losses of $(0.33) per share from the same period last year.